ΠΟΛΙΤΙΚΗ

Resler, a «dealer» of Teva at the expense of Greek’s health

Resler, a «dealer» of Teva at the expense of Greek’s health

In early 2011, the Group of Ratiopharm collapsed as the owner of the German pharmaceutical, Adolf Merkle, committed suicide. In March of that same year, while Resler is the German Minister of Public Health, Ratiopharm became the property of the global giant Teva which produces very cheap, anonymous generic medicines.

As we read to the newspaper "To Choni" (The Funnel) that release today, Resler, as Minister of Health, went on with a drug reform that radically reshaped the German pharmaceutical market, turning Ratiopharm (coming from the bad economical state of the whole Merkle Group, that had to do with its owner's suicide) to a huge player in the German and European generics market. Moreover, due to Resler's reform, Germany has been flooded by cheap, anonymous generics leading German newspapers to publishing extensive reports on their side-effects and the hidden dangers to the public health of the German people. Characteristically enough, Resler named his whole campaign after the slogan "Cheap Medicine".

It seems that, now, it's Greece's turn. The German "plan" is already on foot after Merkel's recent visit to Athens. Merkel demanded that Greece implements a new drug prescription system that will de facto focus on the cheapest medicine, fully disregarding the quality factor. Thus, promoting the cheap made in the Third World anonymous generics like the ones produced by Teva and Ratiopharm and forcing high quality branded medicine out of the market.

THE STORY AND THE DARK SPOTS

The full story: Up to a few weeks ago, most Greeks haven't heard the name Ratiopharm. Now they know that it's not just any company. The German pharmaceutical is a "giant" worth millions of euros, employing thousands of German workers, to be found behind many of the anonymous generics in circulation today across Europe. Since March 2011 Ratiopharm is owned by Israeli company Teva. Teva produces very cheap, anonymous generics in countries like India, China, Puerto Rico, Mexico, etc. The Israeli company has managed to dominate the global market of anonymous generics, due to its extremely cheap priced medicine, and in spite the fact that they have often been at the center of controversy when the authorities found out about the insufficient quality standards in Teva's production facilities. Just a few weeks ago a Teva antidepressant was withdrawn from the US market, after it was found to produce a series of dangerous side-effects. Suicidal tendencies, amongst other things!

OUR "FRIEND" RESLER

Today, Mr. Resler is the vise chancellor and German minister of Economy. He is Merkel's "copilot" in the German coalition government. In Greece he is renown from the criticism and anti-Greek statements during every critical moment for the Greek economy. Mr. Resler always finds a negative statement on Greece, always hindering Greek efforts to do away with the crisis.

However, Mr. Resler isn't just criticizing Greece. He was the Minister of Health who conceived and adopted the pharmaceutical reform in Germany. The "Cheap Medicine" reform. We ask ourselves "Practically, who benefited from Resler's reform?" Certainly not German citizens, answer the German Press, emphasizing on the dangerous side-effects of the cheap medicine.

On the other hand, Ratiopharm is a pharmaceutical giant that specializes in very cheap anonymous generics. The group Merkle (to which Ratiopharm belonged before Teva) was facing major economic problems leading its owner's suicide. While Mr. Reslerwas Minister of Health, Ratiopharm was sold to Teva. After Resler's "Cheap Medicine" reform, Ratiopharm (and Teva) are flourishing, as the market was turned towards their products.

Too many coincidences...

"CRIME AND PUNISHMENT"?

German citizens are not hiding their disappointment in Mr. Resler, as his party (FDP) rates have fallen in all regional elections and the opinion polls carried out in view of federal elections don't show any sign of recovery...